The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...
Stroke remains a leading cause of morbidity worldwide, with limited pharmacological options beyond thrombolysis and thrombectomy in the acute phase. Granulocyte colony-stimulating factor (G-CSF), a ...
Value-based programs, such as the Oncology Care Model (OCM), seek to improve care for patients undergoing chemotherapy, while reducing total costs. The purpose of this study is to quantify the impact ...
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis TrACER was a cluster randomized ...
A pilot study has suggested that intense physical exercise may mobilise a smaller but more targeted population of blood stem ...
29 Phase I Stage III/IV melanoma pts (16) Intradermal injection of sargramostim into melanoma lesions and normal skin (as a control) for 10 days at four dose levels (10, 20, 40, and 80 µg/day) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results